
Docital 120mg Injection
Marketer
Aaltramed Healthcare Ltd
Salt Composition
Docetaxel (120mg)
Overview Docital 120mg Injection
Oncaspar 120mg Injection, an anticancer agent, treats breast, non-small cell lung, prostate, and head and neck cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be evident for weeks or months; discontinue only under medical supervision. Common side effects include shortness of breath, constipation, swelling, infections, appetite loss, myalgia, nail problems, pain, and fatigue. Your doctor might prescribe additional medication to mitigate these. Report unexplained bleeding or bruising, sore throat, mouth sores, or fever immediately. This medication can lower blood cell counts, increasing infection risk. Regular blood tests to monitor blood cell levels and liver function are essential. Prior to commencing treatment, disclose any heart, liver, or kidney issues, and all other medications, including antibiotics, to your doctor, as drug interactions are possible. This injection is contraindicated during pregnancy and lactation. Both partners should employ effective contraception throughout treatment to prevent conception.
Uses of Docital 120mg Injection
Cancers affecting the breast, lungs (non-small cell), prostate, and head/neck.
Major Benefits of Docital 120mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Docital 120mg Injection:
- Breathlessness
- Constipation
- Edema (swelling)
- Infection
- Loss of appetite
- Muscle pain
- Nail disorder
- Pain
- Weakness
How to use Docital 120mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Docital 120mg Injection works:
Oncaspar, a 120mg injectable formulation, is a cancer treatment. Its mechanism involves disrupting microtubule networks, essential for cancer cell division and proliferation. This action inhibits tumor growth, ultimately leading to cancer cell death.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Docital 120mg Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Docital 120mg Injection during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in exceptional, life-threatening circumstances where potential benefits clearly outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Docital 120mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingCONSULT YOUR DOCTOR
The effect of Docital 120mg Injection on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
The 120mg Docital injection presents no safety concerns for use in patients with kidney impairment; dosage modification is unnecessary.
LiverCAUTION
For individuals with hepatic impairment, the administration of a 120mg Docital injection requires careful consideration. Dosage modification of the 120mg Docital injection may be necessary. Physician consultation is advised.
What if you forget to take Docital 120mg Injection :
NA
Facts to Know About Docital 120mg Injection
| Label | Value |
|---|---|
| Type of Compound | Taxane-based medications |
| Addictive | None. |
| Type of Medication | Cancer therapies |
| Mechanism of Action | Microtubule-disrupting drugs: Taxane class |
